Dashboard
Manage Tickers

ANGO


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

angiodynamics-announces-ce-mark-approval-for-auryon-system-in-europe
AngioDynamics Announces CE Mark Approval F...
09/03/2024 12:37:52

pdd-holdings-daqo-new-energy-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
PDD Holdings, Daqo New Energy And Other Bi...
08/26/2024 12:25:39

canaccord-genuity-maintains-buy-on-angiodynamics-lowers-price-target-to-13
Canaccord Genuity Maintains Buy on AngioDy...
07/17/2024 19:23:51

Canaccord Genuity analyst William Plovanic maintains AngioDynamics (NASDAQ:ANGO) with a Buy and lowers the price target from...

hc-wainwright--co-reiterates-buy-on-angiodynamics-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Angi...
07/17/2024 10:06:15

HC Wainwright & Co. analyst Yi Chen reiterates AngioDynamics (NASDAQ:ANGO) with a Buy and maintains $14 price target.

nasdaq-edges-lower-morgan-stanley-earnings-top-views
Nasdaq Edges Lower; Morgan Stanley Earning...
07/16/2024 18:31:51

medical-devices-maker-angiodynamics-lays-out-growth-plans-issues-upbeat-annual-guidance
Medical Devices Maker AngioDynamics Lays O...
07/16/2024 17:51:24

AngioDynamics reported a Q4 2024 adjusted EPS loss of $(0.05), beating the consensus of $(0.16). Sales rose 1.9% to $79.1 milli...

why-charles-schwab-shares-are-trading-lower-by-over-7-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Charles Schwab Shares Are Trading Lowe...
07/16/2024 17:06:26

crude-oil-down-1-bank-of-america-posts-upbeat-earnings
Crude Oil Down 1%; Bank of America Posts U...
07/16/2024 16:00:52

unitedhealth-posts-better-than-expected-earnings-joins-angiodynamics-bank-of-america--and-other-big-stocks-moving-higher-on-tuesday
UnitedHealth Posts Better-Than-Expected Ea...
07/16/2024 15:09:23

angiodynamics-forecasts-fiscal-year-2025-adjusted-eps-of-038-042-compared-to-fiscal-2024-pro-forma-adjusted-eps-of-045-versus-consensus-of-049
AngioDynamics Forecasts Fiscal Year 2025 A...
07/16/2024 10:48:40

angiodynamics-forecasts-fiscal-year-2025-sales-of-282m-288m-representing-growth-of-42--64-over-fiscal-2024-pro-forma-revenue-of-2707m-versus-consensus-of-28768m
AngioDynamics Forecasts Fiscal Year 2025 S...
07/16/2024 10:47:10

Med Tech net sales are expected to grow in the range of 10% to 12% Med Device net sales are expected to grow in the range of...

angiodynamics-q4-2024-adj-eps-005-beats-016-estimate-sales-71122m-beat-70891m-estimate
AngioDynamics Q4 2024 Adj EPS $(0.05) Beat...
07/16/2024 10:36:53

hc-wainwright--co-reiterates-buy-on-angiodynamics-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Angi...
05/22/2024 12:05:09

HC Wainwright & Co. analyst Yi Chen reiterates AngioDynamics (NASDAQ:ANGO) with a Buy and maintains $14 price target.

angiodynamics-secures-ce-mark-approval-in-europe-for-alphavac-f18-system
AngioDynamics Secures CE Mark Approval In ...
05/21/2024 21:34:24

The CE Mark for the AlphaVac F1885 System expands treatment options for healthcare professionals in the EU by offering a tool t...

angiodynamics-apex-av-trial-results-assessing-alphavac-f18-system-for-treatment-of-pulmonary-embolism-presented-at-scai-2024-scientific-sessions
AngioDynamics APEX-AV Trial Results Assess...
05/06/2024 20:47:25

New data finds AlphaVac F1885 System safe in patients with acute intermediate-risk pulmonary embolism (PE) and provides signifi...

insiders-buying-zumiez-and-3-other-stocks
Insiders Buying Zumiez And 3 Other Stocks
04/09/2024 11:29:06

Although U.S. stocks closed little changed on Monday, there were a few notable insider trades.

oppenheimer-upgrades-angiodynamics-to-outperform-announces-12-price-target
Oppenheimer Upgrades AngioDynamics to Outp...
04/05/2024 12:40:31

Oppenheimer analyst Steven Lichtman upgrades AngioDynamics (NASDAQ:ANGO) from Perform to Outperform and announces $12 price ...

medical-devices-focused-angiodynamics-unveils-upbeat-2024-financial-outlook-stock-soars
Medical Devices Focused AngioDynamics Unve...
04/04/2024 16:53:06

FDA grants 510(k) clearance to AngioDynamics' AlphaVac F1885 System for pulmonary embolism. Expanded indication broadens tr...

correction-angiodynamic-expects-fy2024-gross-margin-to-be-approximately-52-54-and-adjusted-eps-of-054-to-058-versus-consensus-of-043
CORRECTION: AngioDynamic Expects FY2024 Gr...
04/04/2024 16:13:57

angiodynamic-expects-fy2024-sales-of-270m-275m-reflects-picc-and-midline-businesses-divestiture-and-discontinuance-of-radiofrequency-ablation-and-syntrax-businesses-which-accounted-for-50m-of-prior-guidance-of-320m-325m-vs-consensus-of-31214m
Angiodynamic Expects FY2024 Sales Of $270M...
04/04/2024 11:06:18

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION